India Tightens Surveillance on Unauthorized Sale of GLP-1 Weight Loss Drugs
Government Cracks Down on Unregulated Distribution Channels
New Delhi, March 24: The government has stepped up regulatory surveillance following growing concerns over the emergence of multiple generic variants of...
Novo Nordisk Drops Lawsuit Against Hims & Hers After Agreement to Sell Wegovy and Ozempic Through Platform
Novo Nordisk has dropped its lawsuit against telehealth company Hims & Hers after both firms reached an agreement that will allow the pharmaceutical company’s branded weight loss...
drug advertising
drug development
fda regulations
glp-1drugs
hims & hers
injectable wegovy
legal dispute
novo nordisk
oral wegovy
ozempic
pharmaceutical companies
semaglutide
telehealth
wegovy
weight loss medication